Genfit S.A. (EPA:GNFT)
3.808
+0.074 (1.98%)
Nov 24, 2025, 5:35 PM CET
Genfit Market Cap
Genfit has a market cap or net worth of €185.94 million as of November 24, 2025. Its market cap has decreased by -23.66% in one year.
Market Cap
185.94M
Enterprise Value
217.34M
Revenue
45.13M
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.81
Market Cap Chart
Since December 20, 2006, Genfit's market cap has increased from 146.07M to 185.94M, an increase of 27.29%. That is a compound annual growth rate of 1.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2025 | 185.94M | 5.48% |
| Dec 31, 2024 | 176.27M | 0.17% |
| Dec 29, 2023 | 175.98M | -10.69% |
| Dec 30, 2022 | 197.03M | -8.19% |
| Dec 31, 2021 | 214.62M | 38.52% |
| Dec 31, 2020 | 154.93M | -77.37% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 141.11B |
| Sanofi | 105.04B |
| Sartorius Stedim Biotech | 18.49B |
| bioMérieux | 12.72B |
| Ipsen | 10.44B |
| Eurofins Scientific SE | 10.24B |
| ABIVAX Société Anonyme | 7.75B |
| Virbac | 2.99B |